OpenVSafe by OpenVAERS
Search V-safe

YG8-33361-40098

4 vaccinations 7 coded responses 35 check-ins 6 free-text entries 1 call case
Sex
Male
Age at first dose
56-60
ZIP prefix
524 / IA
Registered
2021-02-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-14
    Registered in v-safe
  2. 2021-02-14
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-14
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-02-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Diarrhoea — Feeling: Good · Diarrhea
    Free text: Hard to tell whether the mild diarrhea is related to the vacination.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-21
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-02-28
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-07
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-07
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-03-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Adverse reaction — Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Free text: Worse symptoms between 12 and 20 hours after injection.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-03-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-03-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-03-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-03-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-14
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-03-21
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-28
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-11
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-18
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-07
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-05
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-01-09
    Dose 3 — Pfizer-BioNTech
  29. 2022-03-07
    Survey response — 12 months, dose 2
    MedDRA: Anosmia, Breakthrough COVID-19, Fatigue, Headache, Myalgia, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Had about 80% of the symptoms of covid. Total loss of smell, fatigue, headache, muscle aches, fever, etc. Was diagnosed with a breakthrough case of covid the day before I was to get my booster.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-03-07
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  31. 2022-03-09
  32. 2022-03-09
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  33. 2022-03-10
  34. 2022-12-15
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  35. 2022-12-20
    Survey response — days 1–6 daily, dose 4
    MedDRA: Fatigue, Nasopharyngitis, Pain — Feeling: Fair · Fatigue or tiredness
    Free text: I did have fatigue and body aches the day after the injection, but symptoms rapidly diminished. I have cold symptoms which have continued since 4 days ago which may be unrelated.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-12-21
    Survey response — days 1–6 daily, dose 4
    MedDRA: Rhinorrhoea, Throat irritation — Feeling: Good
    Free text: Nasal drainage causing tickle in throat.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-12-22
    Survey response — day 7, dose 4
    MedDRA: Cough, Throat clearing, Upper-airway cough syndrome — Feeling: Good · Fatigue or tiredness
    Free text: Nasal drip causing continuos throat clearing or cough.
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-12-29
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  39. 2023-01-05
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  40. 2023-01-12
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  41. 2023-01-19
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  42. 2023-01-26
    Survey response — day 42, dose 4
    MedDRA: Oropharyngeal pain, Respiratory symptom — Feeling: Fair
    MedDRA releases: 2024-11
  43. 2023-03-16
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  44. 2023-06-15
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-14Pfizer-BioNTech
22021-03-07Pfizer-BioNTech
32022-01-09Pfizer-BioNTech No
42022-12-15Pfizer-BioNTech Flu

Call center

ReportedOutcomeVAERS-related outcome
2022-03-07 Successful
2022-03-09
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 4 — days 1–6 daily, dose 1

2021-02-18

Systemic reaction (other): Hard to tell whether the mild diarrhea is related to the vacination.

Release 5 — days 1–6 daily, dose 2

2021-03-08

Systemic reaction (other): Worse symptoms between 12 and 20 hours after injection.

Release 11 — 12 months, dose 2

2022-03-07

Symptoms: Had about 80% of the symptoms of covid. Total loss of smell, fatigue, headache, muscle aches, fever, etc. Was diagnosed with a breakthrough case of covid the day before I was to get my booster.

Release 12 — days 1–6 daily, dose 4

2022-12-20

Systemic reaction (other): I did have fatigue and body aches the day after the injection, but symptoms rapidly diminished. I have cold symptoms which have continued since 4 days ago which may be unrelated.

2022-12-21

Systemic reaction (other): Nasal drainage causing tickle in throat.

Release 12 — day 7, dose 4

2022-12-22

Systemic reaction (other): Nasal drip causing continuos throat clearing or cough.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnosmia · · ✓
SDBreakthrough COVID-19 · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDMyalgia · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓
SDRespiratory symptom · · ✓
SROAdverse reaction ✓ ✓ ✓
SROCough · · ✓
SRODiarrhoea ✓ ✓ ✓
SROFatigue · · ✓
SRONasopharyngitis · · ✓
SROPain · · ✓
SRORhinorrhoea · · ✓
SROThroat clearing · · ✓
SROThroat irritation · · ✓
SROUpper-airway cough syndrome · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release